NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) has announced the Research Specialist Award (R50) for laboratory-based scientists, under its new funding opportunity. The aim of the award is to cultivate stable career options in NCI-funded cancer research for distinguished scientists who wish to continue participating in research, but do not wish to be independent researchers.

The award covers a wide range of areas in cancer research, including basic, translational, clinical, or population science. The R50 award is uniquely for those non-tenure track scientists who play a crucial role in a research program, thereby contributing significantly to the overall biomedical research work.

It should be noted, however, that the competition for this award is expected to be high. Only exceptional scientists who are committed to the continuance of research, specifically under a pre-existing NCI-funded cancer research program, and who do not wish to become independent investigators, will be considered as competitive candidates for the award.

In conclusion, this award does not permit clinical trials. This opportunity represents NCI's commitment to nurturing a conducive environment for scientific talents to grow and thrive, all in the service of advancing the field of cancer research.